Reduction of conformational mobility and aggregation in W60G β2-microglobulin: assessment by 15N NMR relaxation

Devrim Gümral1, Federico Fogolari, Alessandra Corazza

  • 1Dipartimento di Scienze Mediche e Biologiche, Università di Udine, Udine, Italy; Department of Genetics and Bioengineering, Yeditepe University, Istanbul, Turkey.

Insights

Replacing tryptophan at position 60 in beta2-microglobulin (β2M) with glycine reduces its aggregation. This structural change enhances protein rigidity, decreasing amyloid fibril formation in hemodialysis patients.

Area of Science:

  • Biochemistry
  • Structural Biology
  • Medical Biochemistry

Background:

  • Long-term hemodialysis can lead to amyloid pathology caused by beta2-microglobulin (β2M) deposition.
  • The tryptophan residue at position 60 (Trp60) is crucial for β2M's fibrillogenic transition.

Purpose of the Study:

  • To investigate the role of Trp60 in β2M amyloid fibril formation.
  • To compare the structural dynamics and aggregation propensity of wild-type β2M and a W60G mutant.

Main Methods:

  • Comparative (15)N NMR relaxation analysis at 11.4 T and 310 K.
  • Analysis using the reduced spectral density approach.
  • Molecular dynamics (MD) simulations, thermodynamic integration, and hydrodynamic calculations.

Main Results:

  • The W60G β2M mutant exhibits reduced aggregation compared to wild-type β2M.
  • NMR relaxation and MD simulations indicate increased conformational rigidity in the W60G mutant.
  • The mutant protein shows a reduced ability to form amyloid fibrils when seeded.

Conclusions:

  • The conformational rigidity conferred by the W60G mutation is linked to decreased fibril formation.
  • Targeting Trp60 may offer a strategy to mitigate β2M amyloidosis in hemodialysis patients.